Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · Real-Time Price · USD
909.82
+91.05 (11.12%)
Oct 30, 2026, 1:48 PM EDT - Market open
Regeneron Pharmaceuticals Employees
Regeneron Pharmaceuticals had 15,343 employees as of March 31, 2026. The number of employees increased by 185 or 1.22% compared to the same quarter last year. That makes Regeneron Pharmaceuticals the 2,357th largest employer in the world and 569th in the United States.
Employees
15,343
Change (1Y)
185
Growth (1Y)
1.22%
Revenue / Employee
$1,101,232
Profits / Employee
$313,980
Market Cap
90.85B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 15,343 | 185 | 1.22% |
| Dec 31, 2025 | 15,410 | 304 | 2.01% |
| Dec 31, 2024 | 15,106 | 1,656 | 12.31% |
| Dec 31, 2023 | 13,450 | 1,599 | 13.49% |
| Dec 31, 2022 | 11,851 | 1,483 | 14.30% |
| Dec 31, 2021 | 10,368 | 1,245 | 13.65% |
| Dec 31, 2020 | 9,123 | 1,023 | 12.63% |
| Dec 31, 2019 | 8,100 | 700 | 9.46% |
| Dec 31, 2018 | 7,400 | 1,200 | 19.35% |
| Dec 31, 2017 | 6,200 | 800 | 14.81% |
| Dec 31, 2016 | 5,400 | 1,100 | 25.58% |
| Dec 31, 2015 | 4,300 | 1,375 | 47.01% |
| Dec 31, 2014 | 2,925 | 585 | 25.00% |
| Dec 31, 2013 | 2,340 | 390 | 20.00% |
| Dec 31, 2012 | 1,950 | 246 | 14.44% |
| Dec 31, 2011 | 1,704 | 309 | 22.15% |
| Dec 31, 2010 | 1,395 | 366 | 35.57% |
| Dec 31, 2009 | 1,029 | 110 | 11.97% |
| Dec 31, 2008 | 919 | 237 | 34.75% |
| Dec 31, 2007 | 682 | 109 | 19.02% |
| Dec 31, 2006 | 573 | -15 | -2.55% |
| Dec 31, 2005 | 588 | -142 | -19.45% |
| Dec 31, 2004 | 730 | 86 | 13.35% |
| Dec 31, 2003 | 644 | -25 | -3.74% |
| Dec 31, 2002 | 669 | 94 | 16.35% |
| Dec 31, 2001 | 575 | 84 | 17.11% |
| Dec 31, 2000 | 491 | 54 | 12.36% |
| Dec 31, 1999 | 437 | 66 | 17.79% |
| Dec 31, 1998 | 371 | 101 | 37.41% |
| Dec 31, 1997 | 270 | 27 | 11.11% |
| Dec 31, 1996 | 243 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| BeOne Medicines AG | 12,000 |
| Vertex Pharmaceuticals | 6,400 |
| Moderna | 4,700 |
| Genmab | 3,119 |
| Incyte | 2,844 |
| Alnylam Pharmaceuticals | 2,500 |
| argenx SE | 1,863 |
| Insmed | 1,664 |
REGN News
- 3 hours ago - Regeneron rises 13.1% - TheFly
- 5 hours ago - Regeneron Pharmaceuticals Earnings Call Transcript: Q3 2026 - Transcripts
- 5 hours ago - Regeneron Pharmaceuticals Earnings release: Q3 2026 - Filings
- 5 hours ago - Regeneron Pharmaceuticals Quarterly report: Q3 2026 - Filings
- 5 hours ago - Regeneron Pharmaceuticals Slides: Q3 2026 - Filings
- 7 hours ago - Regeneron reports Q3 adjusted EPS $20.07, consensus $16.25 - TheFly
- 7 hours ago - Regeneron Reports Third Quarter 2026 Financial and Operating Results - GlobeNewsWire
- 2 days ago - Regeneron price target raised to $922 from $875 at Canaccord - TheFly